Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)

ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype -WAYNE, Pa., (GLOBE ...

ATI Inc.: Why Aerospace And Defense Growth Makes This A Strong Buy

ATI Inc. gets a Strong Buy and $139.78 target on aerospace/defense growth, 15% EBITDA CAGR, rising FCF and lower leverage.

Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

Assessing ATI (ATI) Valuation After Strong Multi‑Period Share Price Performance

ATI stock at a glance after recent performance ATI (ATI) has drawn fresh attention after a recent mix of short term pullback ...
Guru3D.com

ATI Radeon 9800 XT review

Seek best price for products of this type. Man, what a hectic 12 months in the graphics industry these have been. A couple of weeks after its release, we received the youngest baby from ATI to review ...